SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
(Rule 13d-102)
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*
General Surgical Innovations, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
0003710131
- --------------------------------------------------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following pages)
Page 1 of 4 Pages
<PAGE>
<TABLE>
<CAPTION>
<S> <C> <C>
- -------------------------------------------------------- ---------------------------------------
CUSIP NO. 0003710131 13 G Page 2 of 4 Pages
- -------------------------------------------------------- ---------------------------------------
- ----------- --------------------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
SS OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Thomas Fogarty, M.D. ("Fogarty")
Tax ID Number:
- ----------- --------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ] (b) [X]
- ----------- --------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- ----------- --------------------------------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S. Citizen
- ----------- --------------------------------------------------------------------------------------------------------
NUMBER OF SHARES 5 SOLE VOTING POWER
BENEFICIALLY 1,860,013 shares, of which 27,454 are shares issuable upon exercise
OWNED BY EACH REPORTING PERSON of a stock option.
WITH
-------- -----------------------------------------------------------------------
6 SHARED VOTING POWER
256,270 shares, of which 209,184 are directly owned by Three Arch
Partners, L.P.("TAP") and 47,086 are directly owned by Three Arch
Associates, L.P. ("TAA"). Fogarty is a general partner of Three Arch
Management Partners, L.P. ("TAM"), the general partner of TAP and
TAA, and may be deemed to have shared power to vote these shares.
-------- -----------------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
1,860,013 shares, of which 27,454 are shares issuable upon exercise
of a stock option.
-------- -----------------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
256,270 shares, of which 209,184 are directly owned by TAP and
47,086 are directly owned by TAA. Fogarty is a general partner of
TAM, the general partner of TAP and TAA, and may be deemed to have
shared power to dispose of these shares.
- ----------------------------------- -------- -----------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON 2,116,283
- ----------- --------------------------------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES* [ ]
- ----------- --------------------------------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
16.04%
- ----------- --------------------------------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ----------- --------------------------------------------------------------------------------------------------------
<FN>
* SEE INSTRUCTIONS BEFORE FILLING OUT!
</FN>
</TABLE>
<PAGE>
Page 3 of 4 Pages
This statement amends and restates the Statement on 13(G) (the
"Original Statement") filed by Three Arch Partners, L.P., a
Delaware limited partnership ("TAP"), Three Arch Associates,
L.P., a Delaware limited partnership ("TAA"), Three Arch
Management, L.P., a Delaware limited partnership ("TAM"), Mark
Wan ("Wan"), Wilf Jaeger ("Jaeger") and Thomas Fogarty, M.D.
("Fogarty") (collectively the "Reporting Persons"). Only those
items as to which there has been a change are included in this
Amendment.
ITEM 4. OWNERSHIP:
The following information with respect to the ownership of the
Common Stock of the issuer by the person filing this Statement
is provided as of December 31, 1997:
(a) Amount beneficially owned:
See Row 9 of cover page for the Reporting Person.
(b) Percent of Class:
See Row 11 of cover page for the Reporting Person.
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
See Row 5 of cover page for the Reporting Person.
(ii) Shared power to vote or to direct the vote:
See Row 6 of cover page for the Reporting Person.
(iii) Sole power to dispose or to direct the
disposition of:
See Row 7 of cover page for the Reporting Person.
(iv) Shared power to dispose or to direct the
disposition of:
See Row 8 of cover page for the Reporting Person.
<PAGE>
Page 4 of 4 Pages
SIGNATURES
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: February 11, 1998
/s/ Mark Wan
----------------------------------------------
Mark Wan, individually and on behalf of TAP in
his capacity as a general partner of TAM, the
general partner of TAP, and on behalf of TAA
in his capacity as a general partner of TAM,
the general partner of TAA, and on behalf of
TAM in his capacity as a general partner
thereof.
/s/ Wilf Jaeger
----------------------------------------------
Wilf Jaeger
/s/ Thomas Fogarty, M.D.
----------------------------------------------
Thomas Fogarty, M.D.
